Press Releases

Psoriasis and Psoriatic Arthritis Treatment Passes Phase II Clinical Trials: Significant Improvement, No Adverse Effects

Psoriasis and Psoriatic Arthritis Treatment Passes Phase II Clinical Trials: Significant Improvement, No Adverse Effects

20.08.2003

Biochemistry, Immunology, Disease, Drugs & Diagnostics

Phase III in psoriasis to be initiated later this year

Christopher Reeve Meets with Elad Wassa, who survived the May 19, 2002 terrorist attack in Netanya. Mr. Reeve is in Israel for a four-day visit.

Christopher Reeve comes to Weizmann Institute

29.07.2003

"The curiosity and thirst for knowledge of the scientists at the Weizmann Institute of Science bring hope for a better scientific and medical future."

Multi-National Team of Physicists, Including Weizmann Institute Scientists:

Multi-National Team of Physicists, Including Weizmann Institute Scientists:

12.06.2003

Particle Physics

"Promising indications that we may have succeeded in reproducing matter as it first appeared in the universe right after the Big Bang"

Glucocerebrosidase

Weizmann Institute Scientists Solve the 3-D Structure of the Enzyme Involved in Gaucher Disease

02.06.2003

Biochemistry, Brain & Behavior, Disease, Drugs & Diagnostics, Structural Biology

The discovery may help design effective therapies for the genetic disease that mainly affects Ashkenazi Jews

Prof. Dan Yakir

Greenhouse Gas Might Green Up the Desert

12.05.2003

Environment, Plants and Agriculture

Weizmann Institute study suggests that rising carbon dioxide levels might cause forests to spread into dry environments

Prof. Adi Shamir

Prestigious Award in Computer Science to Weizmann Institute's scientist

15.04.2003

Prof. Adi Shamir, a computer scientist at the Weizmann Institute of Science, has been named a 2002 winner of the A.M. Turing Award, regarded in academic circles as the 'Nobel Prize' of computer science.

First Sightings of Individual Proteins as They Fold

First Sightings of Individual Proteins as They Fold

01.03.2003

Space & Physics, Biochemistry, Disease, Drugs & Diagnostics

Proteins, it appears, have taken Frank Sinatra's "I Did It My Way" close to heart. A new study published in the current issue of Proceedings of the National Academy of Sciences (PNAS) reveals how single proteins, each a few nanometers (billionths of a meter) long, fold to assume their final shape. It shows that even proteins having the same final shape achieve it by taking different routes.

Experiment May Help Size Up Neutrinos

Experiment May Help Size Up Neutrinos

01.03.2003

Particle Physics

Our planet is bombarded every second with a large number of chargeless, seemingly massless, particles that originate in nuclear fusion reactions that power the sun. They're called neutrinos.

How Humans Lost Their Scents

How Humans Lost Their Scents

01.03.2003

In at least one type of endeavor, humans can’t even begin to compete with their best friends. Dogs can be trained to sniff out drugs and explosives or to track down a crime suspect by smell. Why can’t we do the same? Scientists from the Weizmann Institute of Science and the Max Planck Institute for Evolutionary Anthropology propose an explanation for this ancient quandary.

NMR - The Movie

NMR - The Movie

24.02.2003

Space & Physics, Chemistry

Ten construction workers will often get a job done faster than one. But in digging a deep well, for instance, ten workers are a waste of human resources: the diggers can't work simultaneously, as the second worker isn't able to start digging until the first one has finished, and so on.

Pages

Are you a journalist? Please sign up here for our press releases

Most Popular Articles

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research